Omega Therapeutics (OMGA)
NASDAQ:OMGA
US Market
Holding OMGA?
Track your performance easily

Omega Therapeutics (OMGA) Financial Statements

369 Followers

Omega Therapeutics Financial Overview

Omega Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.43; its P/E ratio is -0.76; Omega Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 2.13M$ 989.00K$ 831.00K$ 759.00K$ 516.00K
Gross Profit$ 2.13M$ 1.17M$ 1.44M$ 759.00K$ 516.00K
EBIT$ -16.60M$ -20.70M$ -22.90M$ -30.64M$ -25.96M
EBITDA$ -15.92M$ -18.92M$ -21.04M$ -28.87M$ -24.60M
Net Income Common Stockholders$ -16.30M$ -20.21M$ -22.25M$ -29.69M$ -25.28M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 45.90M$ 73.43M$ 89.30M$ 112.98M$ 136.79M
Total Assets$ 168.22M$ 204.37M$ 217.81M$ 229.05M$ 156.31M
Total Debt$ 126.90M$ 128.40M$ 131.20M$ 118.63M$ 22.23M
Net Debt$ 81.00M$ 54.97M$ 41.90M$ 5.65M$ -114.55M
Total Liabilities$ 141.91M$ 146.35M$ 141.76M$ 133.11M$ 33.31M
Stockholders Equity$ 26.26M$ 58.02M$ 76.04M$ 95.92M$ 123.00M
Cash Flow-
Free Cash Flow$ -13.10M-$ -23.76M$ -24.31M$ -28.11M
Operating Cash Flow$ -12.70M$ -17.11M$ -23.04M$ -23.27M$ -28.11M
Investing Cash Flow$ -396.00K$ 2.14M$ -724.00K$ 24.05M$ 22.05M
Financing Cash Flow$ -1.11M$ 1.63M$ -8.00K$ 219.00K$ 39.99M
Currency in USD

Omega Therapeutics Earnings and Revenue History

Omega Therapeutics Debt to Assets

Omega Therapeutics Cash Flow

Omega Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis